Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 229-240 of 12,112
Drug study icon
RecruitingNCT03423680

Abilify® Tablet(Aripiprazole) for depression in bipolarity

This study is recruiting in South Korea. It is testing abilify® Tablet(Aripiprazole) for depression in bipolarity.

In Seoul
Bipolarity, DepressionOtherFrom 19 Years to 70 Years
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT07286175

Brenipatide in adults with Bipolarity (RENEW-Bipolar-1)

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for Bipolarity.

Multiple locations, including Orange
BipolarityDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Bipolarity
Other study type icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.

Multiple locations, including Moorpark
DepressionOtherFrom 18 Years to 75 Years
Countries
United States, Australia, Canada, ...
Sponsor
Eli Lilly and Company
Condition
Depression
Other study type icon
RecruitingNCT07410507

Brenipatide in adults with Schizophrenia

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07053345

Esketamine Nasal Spray for treatment-resistant depression

This study is recruiting in South Korea. It is testing esketamine Nasal Spray for treatment-resistant depression.

Multiple locations, including Goyang Si Gyeonggi Do
DepressionOtherFrom 18 Years to 64 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Depression
Other study type icon
RecruitingISRCTN81388388

Home-use brain stimulation to treat Depression in bipolarity

This study is recruiting in the United Kingdom. It is testing home-use brain stimulation to treat Depression for depression in bipolarity.

In United Kingdom
Bipolarity, DepressionOtherFrom 18 Years to 110 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.